QUIXIN

LOE Approaching

levofloxacin

NDAOPHTHALMICSOLUTION/DROPSPriority Review
Approved
Aug 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT03828201Phase 2Recruiting

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Started Jun 2022
220 enrolled
Tuberculosis, Multidrug-Resistant
NCT04214821Phase 1/2Unknown

The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

Started Sep 2019
NCT04212429Phase 1/2Unknown

The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

Started Sep 2019
NCT04212078Phase 1/2Unknown

Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime

Started Jul 2019
NCT03757234Phase 2Completed

IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis

Started Nov 2018
201 enrolled
Acute Pyelonephritis